Related Experiment Video
Updated: Jun 9, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Thromboelastometry-Based Prophylaxis for Venous Thromboembolism in the Acute Period Following Isolated Severe
Anastasia I Baranich1, Aleksandr A Sychev1, Ivan A Savin1
1Neurocritical Care Department, N.N. Burdenko National Medical Research Center of Neurosurgery of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Early VTE prophylaxis (3-4 days) in severe traumatic brain injury (TBI) patients is safe. Rotational thromboelastometry (ROTEM) helps identify hypercoagulation, optimizing treatment timing and reducing risks.
Area of Science:
- Neurotrauma
- Hematology
- Critical Care Medicine
Background:
- Traumatic brain injury (TBI) significantly increases the risk of venous thromboembolism (VTE).
- Determining the optimal timing for VTE prophylaxis in severe TBI patients is crucial for patient safety.
Purpose of the Study:
- To establish the ideal timing for initiating pharmacological VTE thromboprophylaxis in patients with isolated severe TBI.
- To utilize rotational thromboelastometry (ROTEM) for guiding VTE prophylaxis decisions.
Main Methods:
- An observational study involving 115 adult patients with isolated severe TBI within 48 hours of injury.
- Rotational thromboelastometry (ROTEM) was used to assess hypercoagulation, specifically clot density (MCF EXTEM) and fibrinogen levels (MCF FIBTEM).
- VTE chemoprophylaxis initiation timing was correlated with brain CT findings regarding hemorrhagic progression.
Main Results:
- Hypercoagulation, indicated by elevated MCF EXTEM and MCF FIBTEM, was observed in a significant portion of patients by day 7 (85.2%).
- Early VTE chemoprophylaxis initiated on days 3-4 post-TBI did not lead to the progression of hemorrhagic foci in patients.
- ROTEM identified hypercoagulation, suggesting a potential window for intervention.
Conclusions:
- Rotational thromboelastometry (ROTEM) is clinically significant for managing VTE risk in severe TBI.
- Initiating anticoagulant prophylaxis 3-4 days after severe TBI appears safe, with minimal risk of hemorrhagic progression.
- This study provides data to optimize VTE chemoprophylactic strategies in TBI patients, potentially reducing complications.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Traumatic Brain Injury l: Introduction

